A point of disruption

Christopher A. Ross and Russell L. Margolis
Additional contact information
Christopher A. Ross: Neurology and Neuroscience, and in the Program in Cellular and olecular Medicine.
Russell L. Margolis: and in the Program in Cellular and Molecular Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287, USA. caross@jhu.edu

Nature, 2009, vol. 458, issue 7241, 976-977

Abstract: Much is still to be learned about the molecular basis of mental disorders. The identification of a signalling pathway that is affected in schizophrenia, and which thus provides potential therapeutic targets, is a welcome advance.

Date: 2009
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/458976a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:458:y:2009:i:7241:d:10.1038_458976a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/458976a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().